Latest news with #GenesisCare
Time Business News
6 days ago
- Health
- Time Business News
Imaging Boom Drives Cancer Detection and Healthcare Growth
Cancer is a condition where cells in a specific part of the body start multiplying out of control, often clumping together to form tumors. Doctors can identify cancer using different kinds of tests, including imaging scans, endoscopy, tumor marker tests, biopsies, complete blood counts, and MRI scans. Major growth factor consist of large number of clinics have adopted tools for cancer detection like MRI, CT-scans and other. This has led to growth in healthcare sector and global economy. It is also a milestone for healthcare services. Key Growth Drivers and Opportunities Growing Incidence of Cancer: The increasing prevalence and incidences of various types of cancer like lung cancer and breast cancer, help the cancer diagnostics market to grow significantly during the forecast period. According to estimates, 1 in 100 (or 1% yearly) of those 70 years of age or over lost their lives to cancer in 2019. Overall death toll is rising in tandem with the world's population growth. From roughly 46 million in 1990 to 56 million in 2019, there have been more fatalities. Most cancer deaths occur in elderly adults. Rising Expenditure of Healthcare: The cost estimates cover both prescription medications taken by mouth and medical treatments for cancer. The most expensive medical services nationally were linked to non-Hodgkin lymphomas, as well as cancers of the prostate, lung, colon, and female breast. Medical services care costs, which comprise Medicare payments as well as patient obligations for all billed medical services, such as hospitalizations, outpatient hospital services, physician/supplier services, infusion or injectable drug, durable medical equipment, and hospice care, were estimated from Medicare Parts A and B claims. Challenges The implementing cancer diagnostics can require significant upfront investment, including the cost of the software itself, customization, and integration with existing systems. This can be a barrier for smaller hospitals with limited budgets. The regulatory landscape for cancer diagnostics is constantly evolving, with new guidelines and requirements emerging regularly. Keeping up with these changes and adjusting reporting practices accordingly can be a daunting task for companies Innovation and Expansion Guardant, Boehringer Team Up on HER2 NSCLC Liquid Biopsy In December 2024, the Guardant Health, Inc. announced a partnership with Boehringer Ingelheim aimed at obtaining regulatory approval and advancing the commercialization of the Guardant360 CDx liquid biopsy. This partnership is all about using liquid biopsy as a companion diagnostic (CDx) for zongertinib. Zongertinib is a new type of drug called a covalent tyrosine kinase inhibitor (TKI) designed to specifically target HER2 in non-small cell lung cancer (NSCLC), while minimizing the impct on the epidermal growth factor receptor (EGFR). GE, GenesisCare Partner to Tackle Cancer and Heart Disease In November 2020, GE Healthcare entered into partnership with GenesisCare to improve patient outcomes for the two biggest health burdens globally, cancer and heart disease. GE Healthcare will provide CT, MRI, PET/CT, SPECT, digital mammography, and ultrasound equipment to GenesisCare's 440+ cancer and cardiovascular disease treatment centers across Australia, the US, the UK, and Spain This partnership is all about boosting how accurately we can diagnose conditions and making treatment plans smoother, all thanks to state-of-the-art imaging tech. With GE Healthcare's innovative tools, GenesisCare can really speed up spotting issues early on and providing tailored care for folks dealing with cancer or heart-related conditions. Inventive Sparks, Expanding Markets The Key players in the global cancer diagnostics market includes, Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company among others. As major key players, they're effectively striving in innovation to make sure consumers globally can benefit from modern healthcare tech and to really elevate the overall experience for patients everywhere. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
Daily Mail
24-06-2025
- Entertainment
- Daily Mail
EXCLUSIVE Samantha Womack details her 'terrifying' breast cancer battle and the 'mad' performance she gave on the West End amid her diagnosis
After shooting to stardom at the age of just 18 representing Britain on Eurovision, Samantha Womack went onto become one of the most recognised characters on EastEnders. The actress, 52, later moved into the world of theatre, starring in a number of West End productions including The Girl On The Train and The Lion, The Witch and The Wardrobe. But while her career continued to flourish, Samantha was fighting a 'terrifying' battle away from the stage with breast cancer. In an exclusive interview with MailOnline, she has now opened up about the illness, revealing that the 'voice in the back of her head' saved her life. Samantha - who has teamed up GenesisCare for their Keep Abreast of your Breast Density campaign - discovered that she may have breast cancer during a routine check-up in between appearances as the White Witch on the West End in 2021. 'I didn't have any lumps or feel ill,' she said, 'I've never been a doctor person so in the middle of two shows I went for a check-up not expecting to find anything. 'So I went for the ultrasound and there was a little screen on the wall in the doctors' room, looking at it afterwards we saw this little black shadow that wasn't a circle. 'My step-dad is a doctor and I knew that most things natural are circular. Everyone just went quiet. 'In my brain, I did think, "there you are". I do feel like somewhere in our brains, our intuition is important. I've learnt to listen to that voice in my head as it basically saved my life.' While nothing had been confirmed, the mother-of-two says she 'knew' that she had cancer after the first scan. Yet she had to get back on stage and continue performing, and recalls going 'mad' on-stage as the reality of the situation sunk in. 'I hadn't thought the whole thing through, I think we all knew that it was cancer but it hadn't been confirmed yet,' she said. 'I didn't have any time to think about going back to the theatre to do a second show. I was playing the White Witch, and the play's all about life and death and how close those two things are. 'For my entrance, I was lifted into the sky on this machine and all of this snow is coming down, there's cello music playing. 'I just remember having this moment of floating in all this snow, looking out into all this black space - I couldn't process what was happening. 'It was sinking in on-stage in front of everybody. I was mad that evening, I was doing all kinds of crazy things. In a way I was letting go of everything.' Samantha was later diagnosed with an 'aggressive' high grade three form of breast cancer which had already started spreading and - if identified later - could easily have proved fatal. She underwent both chemotherapy and radiotherapy, describing the treatment as a 'rollercoaster'. Samantha added: 'Going through treatment is suddenly just so adrenaline-fueled. 'All of a sudden you're hearing words and terms you've never heard before. You're going to appointments you've never been to before. Things are happening to your body that feel weird. 'It's all a blur to me looking back. I remember some things like coming back home and smelling the chemotherapy on my skin. I love smells so that was terrible, I hated that.' Samantha was relieved to hear she was cancer-free six months after diagnosis - but admits the disease could have been a 'death sentence' if discovered any later. Three years on from her recovery and the actress is now working with Genesis Care to help educate woman going through breast cancer diagnosis. Working on their Keep Abreast of Breast Density campaign, Samantha is encouraging women to ask vital questions during mammograms in order to get the information needed to fight the disease. In particular, the EastEnders star is hoping to raise awareness about breast density. Women with extremely dense breasts are shockingly six times more likely than those with fatty breasts to get breast cancer. 'Cancer-free's a weird term,' Samantha said, 'we all have cancer in our cells all the time, so there's always a chance it can come back. 'To get a proper diagnosis you need proper information. There are four types of breast density, A, B C and D, but if you're extremely dense it's really difficult to spot a tumour. 'There are options though, if there's anything bothering you at any time, you can instigate these investigations on your own. GenesisCare are empowering women to ask the right questions, and they will tell you what your breast density is. 'Early diagnosis is the difference between cancer sounding like a death sentence and like something you can work through.' Having beaten cancer, Samantha says that she now feels 'better' than ever. 'I feel more centered than I've ever been before,' the mother-of-two added. 'I'd basically been constantly working non-stop since I was a kid, so cancer gave me that time to reflect. 'I just feel better, I feel calmer, I feel happier. I'm able to work out what idiots I want to be around and what idiots I don't much more quickly now. It feels nice.' Samantha Womack is partnering with private cancer care provider GensisCare to encourage women to Keep Abreast of their Breast Density. For more information on Dense Breast and Rapid Breast MRI scans, visit Breast cancer is one of the most common cancers in the world and affects more than two MILLION women a year Breast cancer is one of the most common cancers in the world. Each year in the UK there are more than 55,000 new cases, and the disease claims the lives of 11,500 women. In the US, it strikes 266,000 each year and kills 40,000. But what causes it and how can it be treated? What is breast cancer? It comes from a cancerous cell which develops in the lining of a duct or lobule in one of the breasts. When the breast cancer has spread into surrounding tissue it is called 'invasive'. Some people are diagnosed with 'carcinoma in situ', where no cancer cells have grown beyond the duct or lobule. Most cases develop in those over the age of 50 but younger women are sometimes affected. Breast cancer can develop in men, though this is rare. Staging indicates how big the cancer is and whether it has spread. Stage 1 is the earliest stage and stage 4 means the cancer has spread to another part of the body. The cancerous cells are graded from low, which means a slow growth, to high, which is fast-growing. High-grade cancers are more likely to come back after they have first been treated. What causes breast cancer? A cancerous tumour starts from one abnormal cell. The exact reason why a cell becomes cancerous is unclear. It is thought that something damages or alters certain genes in the cell. This makes the cell abnormal and multiply 'out of control'. Although breast cancer can develop for no apparent reason, there are some risk factors that can increase the chance, such as genetics. What are the symptoms of breast cancer? The usual first symptom is a painless lump in the breast, although most are not cancerous and are fluid filled cysts, which are benign. The first place that breast cancer usually spreads to is the lymph nodes in the armpit. If this occurs you will develop a swelling or lump in an armpit. How is breast cancer diagnosed? Initial assessment: A doctor examines the breasts and armpits. They may do tests such as a mammography, a special x-ray of the breast tissue which can indicate the possibility of tumours. Biopsy: A biopsy is when a small sample of tissue is removed from a part of the body. The sample is then examined under a microscope to look for abnormal cells. The sample can confirm or rule out cancer. If you are confirmed to have breast cancer, further tests may be needed to assess if it has spread. For example, blood tests, an ultrasound scan of the liver or a chest X-ray. Treatment options which may be considered include surgery, chemotherapy, radiotherapy and hormone treatment. Often a combination of two or more of these treatments are used. Surgery: Breast-conserving surgery or the removal of the affected breast depending on the size of the tumour. Radiotherapy: A treatment which uses high energy beams of radiation focused on cancerous tissue. This kills cancer cells, or stops them from multiplying. It is mainly used in addition to surgery. Chemotherapy: A treatment of cancer by using anti-cancer drugs which kill cancer cells, or stop them from multiplying. Hormone treatments: Some types of breast cancer are affected by the 'female' hormone oestrogen, which can stimulate the cancer cells to divide and multiply. Treatments which reduce the level of these hormones, or prevent them from working, are commonly used in people with breast cancer. How successful is treatment? The outlook is best in those who are diagnosed when the cancer is still small, and has not spread. Surgical removal of a tumour in an early stage may then give a good chance of cure. The routine mammography offered to women between the ages of 50 and 71 means more breast cancers are being diagnosed and treated at an early stage.
Sydney Morning Herald
11-06-2025
- Health
- Sydney Morning Herald
My cancer diagnosis was terrifying, but there are more reasons than ever to stay positive
The video released this week by Prue Car, announcing that she is facing her second cancer diagnosis in less than three years, comes as a great shock to the state. But her moving and personal message also showed why Prue is what Premier Chris Minns calls 'the toughest, most resilient colleague' in the NSW government. The upside is that the deputy premier will be receiving the very best medical treatment, and she can be assured of Australia's best wishes for a speedy recovery so that she can return to work in due course. Because the cancer has been spotted early in its development, the chances of successful treatment are greatly improved. In recent decades treatments have made huge progress and survival rates are much better. I should know. I was diagnosed with bowel cancer in late 2023. A routine colonoscopy revealed a tumour on my outer bowel rim. A flurry of appointments and tests concluded I had stage three cancer. My first thought was: 'How can this be?' After all, I was reasonably fit and healthy at age 52. I suffered no symptoms: there was no diarrhoea or constipation, or blood in the toilet bowel. But I do have a family history – my 61-year-old mother had died from bowel cancer, and younger Australians are increasingly being diagnosed with the disease. Loading Then I thought: 'How much longer am I going to live?' But the magnificent GenesisCare team at the Royal North Shore Hospital were unfailingly positive, and I was told that my condition was eminently treatable and that I'd probably survive. My treatment started almost immediately: surgery to remove the tumour, followed by intense chemotherapy. The process was disruptive, even distressing: I used to think that my chemo days amounted to a combination of being hungover and seasick at the same time. I put on weight, felt tired, even discombobulated. I ended my weekly Radio National program, which I had presented for 10 years. I made a will. Six months of chemo blasted the cancer, but blasted me too. I'm now in remission, though I continue to experience what's called peripheral neuropathy. It's like constant numbness, tingling, hypersensitivity in one's feet and hands, with no relief in sight. But I've survived thanks to my doctors, (mainly Irish) nurses and loving family and friends. And I still need to pay regular hospital visits for scans, blood tests and check-ups.
The Age
11-06-2025
- Health
- The Age
My cancer diagnosis was terrifying, but there are more reasons than ever to stay positive
The video released this week by Prue Car, announcing that she is facing her second cancer diagnosis in less than three years, comes as a great shock to the state. But her moving and personal message also showed why Prue is what Premier Chris Minns calls 'the toughest, most resilient colleague' in the NSW government. The upside is that the deputy premier will be receiving the very best medical treatment, and she can be assured of Australia's best wishes for a speedy recovery so that she can return to work in due course. Because the cancer has been spotted early in its development, the chances of successful treatment are greatly improved. In recent decades treatments have made huge progress and survival rates are much better. I should know. I was diagnosed with bowel cancer in late 2023. A routine colonoscopy revealed a tumour on my outer bowel rim. A flurry of appointments and tests concluded I had stage three cancer. My first thought was: 'How can this be?' After all, I was reasonably fit and healthy at age 52. I suffered no symptoms: there was no diarrhoea or constipation, or blood in the toilet bowel. But I do have a family history – my 61-year-old mother had died from bowel cancer, and younger Australians are increasingly being diagnosed with the disease. Loading Then I thought: 'How much longer am I going to live?' But the magnificent GenesisCare team at the Royal North Shore Hospital were unfailingly positive, and I was told that my condition was eminently treatable and that I'd probably survive. My treatment started almost immediately: surgery to remove the tumour, followed by intense chemotherapy. The process was disruptive, even distressing: I used to think that my chemo days amounted to a combination of being hungover and seasick at the same time. I put on weight, felt tired, even discombobulated. I ended my weekly Radio National program, which I had presented for 10 years. I made a will. Six months of chemo blasted the cancer, but blasted me too. I'm now in remission, though I continue to experience what's called peripheral neuropathy. It's like constant numbness, tingling, hypersensitivity in one's feet and hands, with no relief in sight. But I've survived thanks to my doctors, (mainly Irish) nurses and loving family and friends. And I still need to pay regular hospital visits for scans, blood tests and check-ups.
